The United States market has shown robust performance recently, with a 1.9% increase over the last week and a 20% rise over the past year, while earnings are projected to grow by 19% annually. In such an environment, identifying stocks that may be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on favorable market conditions.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Robert Half (RHI)	$30.70	$60.28	49.1%
Rayonier (RYN)	$21.28	$40.84	47.9%
Natera (NTRA)	$271.45	$542.56	50%
Intapp (INTA)	$25.21	$50.10	49.7%
Gold Royalty (GROY)	$2.76	$5.35	48.4%
Genuine Parts (GPC)	$117.98	$225.98	47.8%
Dime Commercial Bancshares (DCOM)	$40.65	$80.97	49.8%
ConnectOne Bancorp (CNOB)	$33.44	$66.52	49.7%
Beacon Financial (BBT)	$30.45	$60.25	49.5%
Alnylam Pharmaceuticals (ALNY)	$301.03	$598.21	49.7%

Here's a peek at a few of the choices from the screener.

Alnylam Pharmaceuticals (ALNY)

Overview: Alnylam Pharmaceuticals, Inc. focuses on discovering, developing, manufacturing, and commercializing therapeutics based on ribonucleic acid interference across the United States, Europe, and internationally with a market cap of $39.19 billion.

Operations: The company's revenue is primarily derived from its activities in the discovery, development, manufacturing, and commercialization of RNAi therapeutics, totaling $4.29 billion.

Estimated Discount To Fair Value: 49.7%

Alnylam Pharmaceuticals is trading at US$301.03, significantly below its estimated future cash flow value of US$598.21, indicating potential undervaluation based on cash flows. The company's earnings are expected to grow significantly at 27.9% annually, outpacing the broader US market's growth rate. Alnylam's recent strategic partnerships and AI integrations aim to enhance therapeutic innovation and operational efficiency, potentially supporting its ambitious revenue growth forecasts of 19.4% per year above the market average.

FTAI Aviation (FTAI)

Overview: FTAI Aviation Ltd. is involved in owning, acquiring, and selling aviation equipment for global transportation purposes, with a market cap of $27.04 billion.

Operations: The company's revenue is primarily derived from two segments: Aviation Leasing, which contributes $521.03 million, and Aerospace Products, generating $2.31 billion.

Estimated Discount To Fair Value: 21.1%

FTAI Aviation is trading at US$270.53, over 20% below its estimated future cash flow value of US$342.8, suggesting it may be undervalued based on cash flows. The company's earnings are projected to grow significantly at 28.6% annually, surpassing the US market's growth rate. Despite recent index exclusions and insider selling, FTAI's increased credit facility supports strategic market opportunities and long-term shareholder value creation amidst high revenue growth forecasts of 21.9% per year.

Sea (SE)

Overview: Sea Limited operates as a technology company through its subsidiaries across Southeast Asia, Latin America, and other international markets, with a market cap of approximately $56.93 billion.

Operations: The company's revenue is primarily derived from its E-commerce segment, Shopee, at $18.15 billion, followed by Digital Financial Services, Monee, at $4.25 billion and Digital Entertainment, Garena, at $2.61 billion.

Estimated Discount To Fair Value: 38.4%

Sea is trading at US$95.83, over 38% below its estimated future cash flow value of US$155.56, highlighting potential undervaluation based on cash flows. Despite revenue growth forecasts of 15.8% annually being slower than the 20% benchmark, earnings are expected to grow significantly at 24.1%, outpacing the US market's average growth rate. Recent buybacks and a rise in quarterly net income to US$427.94 million further underline its financial resilience and shareholder value focus.

Taking Advantage

• Click here to access our complete index of 129 Undervalued US Stocks Based On Cash Flows.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.